Authorship note: sc and fv are co-first authors. lmm and gk are co-senior authors. conflict of interest: yyz reported provisional patents titled “plga-peg nanoparticles and methods of uses,” “cationic polymer-formulated use,” “methods and compositions for the treatment of pulmonary hypertension and cancer,” “methods and compositions for the treatment of covid-19 and associated respiratory distress and multi-organ failure, sepsis, acute respiratory distress syndrome, and cardiovascular diseases,” “use of stromal cell-derived factor 1 (sdf1) as a biomarker for diagnosis and treating severe acute respiratory distress syndrome (ards),” and “treatment of cystic fibrosis class i mutations,” all pending. yyz is the founder and chief scientific officer of mountview therapeutics llc

HIGHLIGHTS

• who: Slaven Crnkovic and colleagues from the Ludwig Boltzmann InstituteMedical University of Graz, Graz, Austria have published the research: Authorship note: SC and FV are co-first authors. LMM and GK are co-senior authors. Conflict of interest: YYZ reported provisional patents titled u201cPLGA-PEG nanoparticles and methods of uses,u201d u201cCationic polymer-formulated use,u201d u201cMethods and compositions for the treatment of pulmonary hypertension and cancer,u201d u201cMethods and compositions for the treatment of COVID-19 and associated respiratory distress and multi-organ failure, sepsis, acute respiratory distress syndrome, and cardiovascular diseases,u201d u201cUse of stromal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.